NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

IMO, it is telling that Dr. Steven Brem is on the Steering Committee.

longfellow95 Friday, 07/06/18 12:02:31 PM
Re: None
Post #
181412

Well, it's gratifying to know that in addition to the extremely well qualified Scientific Advisory Board, there is also an extremely well qualified Steering Committee for the trial, and they are all amongst the list of co-authors.

I had not heard them named previously until LP named them at the ASCO meeting.

Steering Committee:-

Dr. Steven Bremm.
Chief, Neurosurgical Oncology, Co-Director, Penn Brain Tumor Center, Professor of Neurosurgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania


Dr. Fabio Iwamoto.
Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors.

Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.


Dr. Jian Campian.
https://oncology.wustl.edu/people/faculty/Campian/Campian_Bio.html


Dr. John Trusheim.

https://www.futuremedicine.com/doi/10.2217/cns-2016-0032

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142024955